Atreo.io

company

About

Atreo.io develop an RTSM solution in the market, revolutionizing the client experience.

  • San Francisco,California,United States
  • 11 - 50

Details

Last Funding Type
Pre-seed
Last Funding Money Raised
$4M
Industries
Health Care,Information Technology,Software
Founded date
Jan 1, 2021
Number Of Employee
11 - 50
Operating Status
Active
Legal Name
Atreo, Inc.

Atreo.io develop an RTSM solution in the market, revolutionizing the client experience.

Atreo’s team has diverse and complementary experience across all aspects of RTSM, Clinical Supplies, and Clinical Trials project delivery and support. Atreo’s team has delivered and supported 1000+ clinical trials for a diverse client pool including emerging Biotechs to top 10 Pharma and CROs.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$5.75M
Atreo.io has raised a total of $5.75M in funding over 2 rounds. Their latest funding was raised on Jun 6, 2022 from a Pre-seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 6, 2022 Pre-seed $4M 3 Jon Dole Detail
May 7, 2021 Pre-seed $1.75M Detail

Investors

Number of Lead Investors
Number of Investors
1
3
Atreo.io is funded by 3 investors. Jon Dole and Cal Henderson are the most recent investors.
Investor Name Lead Investor Funding Round
Jon Dole Yes Pre-seed
Cal Henderson Pre-seed
Stewart Butterfield Pre-seed

Employee Profiles

Number of Employee Profiles
3
Atreo.io has 3 current employee profiles, including Employee Jonathan Dole
Employee
Executive
Executive